Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 6;6(1):e70160.
doi: 10.1002/deo2.70160. eCollection 2026 Apr.

Pancreatic Neuroendocrine Tumor Leading to a Diagnosis of Multiple Endocrine Neoplasia Type 1

Affiliations

Pancreatic Neuroendocrine Tumor Leading to a Diagnosis of Multiple Endocrine Neoplasia Type 1

Noriyuki Hirakawa et al. DEN Open. .

Abstract

Pancreatic neuroendocrine neoplasms are rare but occasionally encountered. They are generally highly vascularized solid tumors, often round in shape with clear boundaries, defined contours, and a homogeneous internal structure. However, they can also present with atypical features, such as cystic degeneration, hemorrhage, calcification, and fibrosis, making diagnosis difficult in some cases. They are also known as comorbidities of multiple endocrine neoplasia type 1 (MEN1). This report describes a case in which endoscopic ultrasound (EUS) led to a diagnosis of MEN1. A 50-year-old man was referred to our hospital for examination of a mass in the pancreatic body. An EUS-guided fine-needle biopsy was performed, and a histological diagnosis of neuroendocrine tumor (NET) was made. In addition, the NET was also identified in the duodenum. Serum calcium and parathyroid hormone levels were elevated. Examination of the parathyroid and pituitary glands revealed concurrent hyperparathyroidism and a pituitary adenoma, confirming the diagnosis of MEN1, including a NET in the duodenum.

Keywords: endoscopic ultrasound | hyperparathyroidism | multiple endocrine neoplasia type 1 | pancreatic neuroendocrine tumor | pituitary adenoma.

PubMed Disclaimer

Conflict of interest statement

Takao Itoi is the Editor‐in‐Chief of DEN Open. Takao Itoi is a consultant for Olympus.

Figures

FIGURE 1
FIGURE 1
Findings on computed tomography (CT). (A) Plain. (B) Arterial phase. (C) Portal venous phase. (D) Delayed phase. On contrast‐enhanced CT, a slight hypervascular mass was observed in the arterial phase at the location indicated by the arrow.
FIGURE 2
FIGURE 2
Findings on endoscopic ultrasound. (A) A 20‐mm hypoechoic mass with relatively clear borders was seen in the pancreatic body. (B) Endoscopic ultrasound‐guided fine‐needle biopsy was performed on the mass in the pancreatic body via the stomach. (C) Contrast‐enhanced harmonic endoscopic ultrasound showed a slight enhancement of the mass in the pancreatic body from an early stage.
FIGURE 3
FIGURE 3
Microscopic observations for the pancreatic tumor. A pancreatic biopsy was performed, and the sample was analyzed by hematoxylin‐eosin staining (A) and immunohistochemical detection using (B) anti‐synaptophysin, (C) anti‐chromogranin A, and (D) anti‐gastrin. The tumor cells had uniform rounded nuclei and pale acidophilic cytoplasm. Scale bar, 50 µm. No mitotic cells were found. The tumor showed synaptophysin and chromogranin positivity, with a Ki‐67 labeling index of less than 1%. The tumor did not express gastrin.

References

    1. Ito T., Igarashi H., Nakamura K., et al., “Epidemiological Trends of Pancreatic and Gastrointestinal Neuroendocrine Tumors in Japan: A Nationwide Survey Analysis,” Journal of Gastroenterology 50 (2015): 58–64. - PubMed
    1. Ito T., Sasano H., Tanaka M., et al., “neuroendocrine Tumors in Japan,” Epidemiological Study of Gastroenteropancreatic 45 (2010.): 234–243. - PubMed
    1. Rv T., pJ N., Walls G. V., et al., “Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type L (MEN 1),” Journal of Clinical Endocrinology and Metabolism 97 (2012): 2990–3011. - PubMed
    1. Sakurai A., Suzuki S., Kosugi S., et al., “Multiple Endocrine Neoplasia Type L in Japan: Establishment and Analysis of a Multicentre Database,” Clin Endocrinol 76 (2012): 533–539. - PubMed
    1. Takumi K., Fukukura Y., Higashi M., et al., “Pancreatic Neuroendocrine Tumors: Correlation Between the Contrast‐enhanced Computed Tomography Features and the Pathological Tumor Grade,” European Journal of Radiology 84 (2015): 1436–1443. - PubMed

LinkOut - more resources